Skip to content
Bills from the 2011–12 session

Assembly Bill 745

Obtaining informed consent for the prescription and use of drugs and devices and granting rule-making authority

Topics: Drugs, Legislature: Criminal Penalties, Joint Review Committee on, Medical Examining Board, Medical service, Physician

Stopped in committee

It never got a ⁠, so it never came up for a vote. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Mar 15, 2012

  2. Committee, stopped here

    Stopped here. No public hearing was held.

  3. Assembly vote, not reached

  4. Senate vote, not reached

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Mar 23, 2012: “Failed to pass pursuant to ⁠”

It never got a hearing in the Assembly Committee on Health. See every bill that never got a hearing this session.

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

Under current law, a physician who treats a patient must inform the patient about the availability of all alternate, viable medical modes of treatment and about the benefits and risks of these treatments. A physician who violates this requirement is subject to discipline by the Medical Examining Board (board) for unprofessional conduct and may be fined up to $25,000 and imprisoned for up to 9 months. If the board finds that the physician has engaged in unprofessional conduct, the board may warn or reprimand the physician, or limit, suspend, or revoke any license, certificate, or limited permit granted to the physician.

Under this bill, a physician may not prescribe or use a drug or device in a manner that constitutes an off-label use without obtaining the patient's informed consent unless the board has determined that the off-label use is safe and effective.

Read the full summary

The bill defines an off-label use as a use that has not been approved by the U.S.

Federal Drug Administration (FDA) to be included on the product's label. The bill specifies that a patient's consent is informed only if the physician informs the patient that the drug or device is being prescribed or used in a manner that is an off-label use and of the uses for which the drug or device has been approved by the FDA.

The bill also provides that, beginning on January 1, 2014, a physician may not prescribe or use any drug or device in which the physician has a financial interest unless the physician obtains the patient's informed consent. Under the bill, a physician has a financial interest in a drug or device if the physician has received gifts or payments of more than $10 from the manufacturer and information about those gifts or payments is available to the public on an Internet Web site. Under federal law, information on gifts or payments of more than $10 from manufacturers to physicians must be available to the public on an Internet Web site no later than September 30, 2013. The bill specifies that a patient's consent is informed only if the physician provides the patient with any information related to gifts or payments the physician received from the manufacturer of a drug or device that is publicly available on the Internet Web site established by the federal government.

Under the bill, a physician who fails to obtain a patient's informed consent related to the off-label use of a drug or device or for the prescription or use of a drug or device in which the physician has a financial interest is subject to the same penalties as a physician who fails to inform a patient about the availability of all alternate, viable medical modes of treatment.

Because this bill creates a new crime or revises a penalty for an existing crime, the Joint Review Committee on Criminal Penalties may be requested to prepare a report concerning the proposed penalty and the costs or savings that are likely to result if the bill is enacted.

Who's behind it

Margaret Krusick, a Democrat, is its ⁠.

See all the details

Author (1)

What happened

  1. Mar 23, 2012

    The session ended, and the bill died with it.

  2. Mar 15, 2012

    Sent to the Assembly Committee on Health.

  3. Mar 15, 2012

    Introduced in the Assembly.

See the official record, word for word
  1. Mar 15, 2012 · Assembly

    Introduced by Representative Krusick

  2. Mar 15, 2012 · Assembly

    Read first time and referred to committee on Health

  3. Mar 23, 2012 · Assembly

    Failed to pass pursuant to Senate Joint Resolution 1

Terms on this page

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

More in the glossary

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor